CRIS Current Research Information System

BARTOLETTI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.421
AS - Asia 6.500
EU - Europa 5.070
SA - Sud America 417
AF - Africa 389
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.302
SG - Singapore 1.874
VN - Vietnam 1.811
CN - Cina 1.414
GB - Regno Unito 1.123
IT - Italia 1.122
SE - Svezia 711
DE - Germania 586
HK - Hong Kong 411
IN - India 299
FR - Francia 291
BR - Brasile 273
RU - Federazione Russa 233
IE - Irlanda 203
NL - Olanda 141
CI - Costa d'Avorio 137
KR - Corea 121
JP - Giappone 112
BG - Bulgaria 111
CH - Svizzera 78
FI - Finlandia 78
ZA - Sudafrica 75
BD - Bangladesh 73
TG - Togo 73
CA - Canada 64
JO - Giordania 63
UA - Ucraina 63
ES - Italia 57
ID - Indonesia 56
AT - Austria 53
AR - Argentina 52
EE - Estonia 47
BE - Belgio 45
PH - Filippine 33
NG - Nigeria 31
TH - Thailandia 28
IQ - Iraq 27
MX - Messico 25
PL - Polonia 24
TR - Turchia 24
TW - Taiwan 21
EC - Ecuador 20
PK - Pakistan 19
SC - Seychelles 19
CL - Cile 17
IR - Iran 17
UZ - Uzbekistan 17
AU - Australia 16
CO - Colombia 16
MY - Malesia 16
SA - Arabia Saudita 15
RO - Romania 14
LT - Lituania 13
HR - Croazia 11
PY - Paraguay 11
TN - Tunisia 11
GR - Grecia 10
KE - Kenya 9
RS - Serbia 9
AE - Emirati Arabi Uniti 8
PE - Perù 8
VE - Venezuela 8
EG - Egitto 6
IL - Israele 6
KZ - Kazakistan 6
PA - Panama 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
HN - Honduras 5
LY - Libia 5
AZ - Azerbaigian 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
JM - Giamaica 4
MA - Marocco 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CR - Costa Rica 3
LB - Libano 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
QA - Qatar 3
BH - Bahrain 2
ET - Etiopia 2
EU - Europa 2
GP - Guadalupe 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
SI - Slovenia 2
SM - San Marino 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZW - Zimbabwe 2
Totale 19.785
Salva come PNG Salva come JPEG
Città #
Singapore 1.325
Southend 999
Ashburn 865
Chandler 634
Fairfield 596
San Jose 397
Ho Chi Minh City 391
Hong Kong 381
Hanoi 345
Santa Clara 313
Wilmington 267
Woodbridge 267
Houston 260
Seattle 243
Ann Arbor 228
Bologna 223
Princeton 216
Cambridge 211
Dong Ket 206
Beijing 203
Dublin 202
Hefei 183
Boardman 175
New York 148
Abidjan 137
Los Angeles 117
Sofia 108
Lauterbourg 105
Council Bluffs 101
Tokyo 100
Seoul 96
Milan 77
Lomé 73
Berlin 66
Bern 62
Nanjing 62
Amman 61
Westminster 60
Da Nang 57
Dallas 56
Redmond 55
Bremen 53
Haiphong 53
Helsinki 52
Frankfurt am Main 51
Shanghai 49
Buffalo 48
Padova 44
Redondo Beach 44
San Diego 43
Brussels 41
Rome 41
Saint Petersburg 40
São Paulo 40
Jakarta 38
Jinan 38
Turin 38
Chicago 37
Florence 35
Guangzhou 35
Munich 35
Falls Church 33
Amsterdam 30
London 28
Vienna 28
Abeokuta 27
Des Moines 27
Redwood City 27
Shenyang 27
Changsha 23
Hải Dương 23
Nuremberg 23
Lappeenranta 22
Toronto 22
Bengaluru 21
Hebei 21
Paris 21
Nanchang 20
Olalla 20
Verona 20
Rimini 19
Bühl 18
Phoenix 18
San Francisco 18
Dearborn 17
Montreal 17
Washington 17
Denver 16
Modena 16
Ningbo 16
Orem 16
Biên Hòa 15
Quận Bình Thạnh 15
Zhengzhou 15
Atlanta 14
Baghdad 13
Brooklyn 13
Hangzhou 13
Warsaw 13
Can Tho 12
Totale 12.300
Salva come PNG Salva come JPEG
Nome #
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 560
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 328
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 316
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 258
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 256
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 254
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 252
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 249
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 238
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 238
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 234
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 229
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 224
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 223
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 220
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 216
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 215
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 212
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 212
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 209
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 205
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 204
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 202
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 201
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 201
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 199
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 198
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 195
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 194
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 193
Advances in the therapy of bacterial bloodstream infections 193
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 192
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 191
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 188
Bloodstream infections in patients with liver cirrhosis 187
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 184
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 183
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 182
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 181
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 180
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 180
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 178
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 178
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 177
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 172
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 170
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 168
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 167
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis 166
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 166
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 166
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 165
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 165
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 164
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 164
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 162
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 160
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 160
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 159
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 159
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 159
ESCMID COVID-19 living guidelines: drug treatment and clinical management 159
The Gut Microbiota of Critically Ill Patients With COVID-19 157
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 156
Outcome Prediction for SARS-CoV-2 Patients Using Machine Learning Modeling of Clinical, Radiological, and Radiomic Features Derived from Chest CT Images 153
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 153
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 153
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 152
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 150
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 150
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 148
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 146
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 144
null 142
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 142
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 141
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 140
Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy 140
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 132
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 131
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 131
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 128
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 127
Opportunistic infections in end stage liver disease 126
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 126
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 125
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 123
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 122
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 121
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 120
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients 120
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 119
Procalcitonin-guided antibiotic therapy: An expert consensus 116
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 114
Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis 114
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 113
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. 112
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 111
How do I manage a patient with enterococcal bacteraemia? 109
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 106
Totale 17.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021497 0 0 0 0 0 0 0 0 0 0 0 497
2021/20222.508 182 78 98 203 170 136 105 214 134 296 472 420
2022/20232.729 251 324 150 362 210 209 84 203 489 122 183 142
2023/20241.039 66 149 62 101 72 230 66 79 43 79 52 40
2024/20252.880 146 384 236 259 432 169 230 97 58 190 151 528
2025/20266.973 619 567 524 470 746 388 776 260 1.507 602 298 216
Totale 20.299